A polymorphism in the visfatin gene promoter is related to decreased plasma levels of inflammatory markers in patients with coronary artery disease

Genetic Variants Identified in a European Genome-Wide Association Study That Were Found to Predict Incident Coronary Heart Disease in the Atherosclerosis Risk in Communities Study

(2009) J. Bressler et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Genetic variant in visfatin gene promoter is associated with decreased risk of coronary artery disease in a Chinese population

(2009) Jian-Jun Yan et al.   CLINICA CHIMICA ACTA

Association of plasma visfatin levels with inflammation, atherosclerosis and acute coronary syndromes (ACS) in humans

(2009) Sheng Wen Liu et al.   CLINICAL ENDOCRINOLOGY

Critical role of PBEF expression in pulmonary cell inflammation and permeability

(2008) P LIU et al.   CELL BIOLOGY INTERNATIONAL

The -1535 Promoter Variant of The Visfatin Gene Is Associated with Serum Triglyceride and HDL-cholesterol Levels in Japanese Subjects

(2008) Ayumi TOKUNAGA et al.   ENDOCRINE JOURNAL

Polymorphisms of the tumor necrosis factor-alpha (TNF) and the TNF-alpha converting enzyme (TACE/ADAM17) genes in relation to cardiovascular mortality: the AtheroGene study

(2008) P. E. Morange et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

C-reactive protein gene polymorphisms affect plasma CRP and homocysteine concentrations in subjects with and without angiographically confirmed coronary artery disease

(2008) Daria Pašalić et al.   MOLECULAR BIOLOGY REPORTS

A common variant on chromosome 9p21 affects the risk of early-onset coronary artery disease

(2008) Zhong Chen et al.   MOLECULAR BIOLOGY REPORTS

Heart Disease and Stroke Statistics—2008 Update

(2007) et al.   CIRCULATION